Harbor Health Care ETF Rating $32.30 +0.53 (+1.67%) Closing price 04:10 PM EasternExtended Trading$32.32 +0.02 (+0.05%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatings Harbor Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDI Aggregate RatingModerate Buy 2.85Holdings in MEDI have an aggregate rating of Moderate Buy based on 494 analyst ratings issued in the past year covering 25 companies (85.8% of the portfolio).MEDI Aggregate Price Target$32.30High Prediction$32.30Average Prediction$32.30Low Prediction$32.30Holdings in MEDI have an aggregate price target of $32.30 and a range of $32.30 to $32.30 covering 25 companies (85.8% of the portfolio).MEDI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Harbor Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 MEDI Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings22.43%LLYEli Lilly and Company$1,211.08+3.8%Moderate Buy$1,313.43 8.5%294.8587 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision16.09%ASNDAscendis Pharma A/S$227.00+1.7%Buy$313.21 38.0%204.787 of 5 starsAnalyst Forecast4.53%ARGXargenex$818.30+2.0%Moderate Buy$1,151.95 40.8%304.7053 of 5 starsAnalyst Forecast3.77%PCVXVaxcyte$67.55+1.1%Moderate Buy$110.50 63.6%92.7486 of 5 starsAnalyst Forecast2.93%INSMInsmed$97.79+1.0%Moderate Buy$200.30 104.8%252.615 of 5 starsTrending NewsAnalyst ForecastOptions VolumeAnalyst RevisionGap Down2.84%RYTMRhythm Pharmaceuticals$86.71+0.1%Moderate Buy$142.56 64.4%212.5983 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision2.42%ABBVAbbVie$283.58+3.4%Moderate Buy$277.18 -2.3%304.1564 of 5 starsTrending NewsAnalyst ForecastOptions VolumeAnalyst Revision2.36%GHGuardant Health$162.99+0.6%Moderate Buy$190.00 16.6%252.3187 of 5 starsAnalyst Forecast2.33%NTRANatera$394.75-0.2%Moderate Buy$368.69 -6.6%231.8681 of 5 starsAnalyst Forecast2.14%DHRDanaher$224.65+0.8%Moderate Buy$235.41 4.8%233.4749 of 5 starsTrending NewsUpcoming EarningsAnalyst Forecast2.06%RVMDRevolution Medicines$193.52+2.7%Moderate Buy$234.81 21.3%242.8291 of 5 starsAnalyst Forecast1.93%MCKMcKesson$977.31+1.6%Moderate Buy$983.29 0.6%194.3562 of 5 stars1.87%PTCTPTC Therapeutics$59.67-0.4%Moderate Buy$98.25 64.7%154.0159 of 5 stars1.79%IDXXIDEXX Laboratories$529.01+1.7%Moderate Buy$747.00 41.2%114.6574 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision1.78%UNHUnitedHealth Group$396.02+4.8%Moderate Buy$461.83 16.6%284.7989 of 5 starsTrending NewsEarnings ReportAnalyst Forecast1.73%UTHRUnited Therapeutics$540.03-0.6%Moderate Buy$639.08 18.3%144.0897 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.71%CORCencora$335.85+1.7%Moderate Buy$365.69 8.9%184.6719 of 5 starsAnalyst Forecast1.71%ABVXAbivax$87.98+2.0%Moderate Buy$156.69 78.1%162.5302 of 5 starsPositive News1.55%HQYHealthEquity$89.87-0.4%Moderate Buy$112.20 24.8%134.424 of 5 stars1.52%INDVIndivior$34.16-3.6%Buy$45.17 32.2%74.5966 of 5 starsPositive News1.40%IONSIonis Pharmaceuticals$42.70+0.8%Moderate Buy$89.20 108.9%223.1781 of 5 stars1.40%MRKMerck & Co., Inc.$147.47+3.9%Moderate Buy$151.92 3.0%274.4309 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision1.23%XENEXenon Pharmaceuticals$33.90-1.5%Moderate Buy$70.14 106.9%154.3955 of 5 starsAnalyst Downgrade1.14%LEGNLegend Biotech$19.04+6.5%Moderate Buy$55.07 189.2%152.6585 of 5 starsAnalyst Forecast1.12%GKOSGlaukos$167.69+1.3%Moderate Buy$181.43 8.2%152.6038 of 5 starsAnalyst Forecast This page (NYSEARCA:MEDI) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredBlackRock is all over this (are you?)BlackRock's new fund hit $2.8 billion in under three months. JPMorgan is now running $2 billion a day through ...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harbor Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Harbor Health Care ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDI Stock Alerts